Roivant Sciences Ltd (ROIV)
11.84
-0.04
(-0.34%)
USD |
NASDAQ |
Dec 13, 16:00
11.72
-0.12
(-1.01%)
After-Hours: 20:00
Roivant Sciences Total Liabilities (Quarterly): 625.99M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Organon & Co | 12.26B |
| AstraZeneca PLC | 64.12B |
| Adaptimmune Therapeutics PLC | 237.45M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| Verona Pharma PLC | 251.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.206B |
| Shareholders Equity (Quarterly) | 5.153B |
| Current Ratio | 10.43 |
| Net Debt Paydown Yield | 1.02% |